Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative
BackgroundDrug-drug interaction (DDI) is one of the main contributors to adverse drug reactions and therefore, it is important to study its frequency in the population. We aimed to investigate frequency and concordance on CYP2D6, CYP2C19, and CYP2C9 (CYP2D6/2C19/2C9)-mediated potential DDIs at the L...
Saved in:
Main Authors: | Muh. Akbar Bahar (Author), Jens H. J. Bos (Author), Sander D. Borgsteede (Author), Aafje Dotinga (Author), Rolinde A. Alingh (Author), Bob Wilffert (Author), Eelko Hak (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride
by: Diana María Campodónico, et al.
Published: (2022) -
Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P‐gp Substrates in Patients With an Advanced Solid Tumor
by: Jim J. Xiao, et al.
Published: (2019) -
Characterisation of <it>CYP2C8</it>, <it>CYP2C9 </it>and <it>CYP2C19 </it>polymorphisms in a Ghanaian population
by: Dodoo Alexander NO, et al.
Published: (2009) -
Substrate Specificity of Human Cytochrome P450 (CYP) 2C Subfamily and Effect of Azole Antifungal Agents on CYP2C8
by: Toshiro Niwa, et al.
Published: (2016) -
Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula
by: Francesco Carano, et al.
Published: (2018)